Journals / Viral Hepatitis Journal / 2014 / Cilt: 20 - Sayı: 3

Delta Hepatitine Bağlı Sirozlu Hastada Hepatosellüler Kanserin Yttrium-90 ile Radyoembolizasyon Tedavisi: Olgu Sunumu

Treatment of Hepatocellular Cancer Due to Hepatitis Delta with Yttrium-90 Radioembolization in a Patient with Cirrhosis: A Case Report

Pages
131–133
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we present a 55-year-old male HCC patient who developed HCC due cirrhosis associated with delta hepatitis and was successfully treated with yttrium-90 radioembolization therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cirrhosis due to delta hepatitis is one of the most important etiologic factors in our country.
📊
Key Findings & Data:Recently, yttrium-90 radioembolization therapy has been increasingly used in the treatment of HCC.
💡
Conclusion & Impact:Herein, we present a 55-year-old male HCC patient who developed HCC due cirrhosis associated with delta hepatitis and was successfully treated with yttrium-90 radioembolization therapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Cirrhosis due to delta hepatitis is one of the most important etiologic factors in our country. Hepatocellular carcinoma (HCC) often develops on the base of cirrhosis. Recently, yttrium-90 radioembolization therapy has been increasingly used in the treatment of HCC. Transarterial infusion of yttrium-90 radioactive microspheres is a new promising method in treating unresectable liver tumors. Herein, we present a 55-year-old male HCC patient who developed HCC due cirrhosis associated with delta hepatitis and was successfully treated with yttrium-90 radioembolization therapy.

Özet

Ülkemizde sirozun önemli etyolojik nedenlerinden biri delta hepatitidir. Hepatosellür kanser (HSK) sıklıkla siroz zemininde gelişmektedir. HSK tedavisinde radyoembolizasyon olarak adlandırılan yttrium-90 tedavisi son yıllarda gittikçe daha yaygın kullanılmaktadır. Radyoaktif mikropartiküllerin transarteryal olarak infüze edilmesinden oluşan ve daha yeni bir yöntem olan radyoembolizasyonun rezeke edilemeyen karaciğer tümörlerinde umut vaat ettiği bildirilmiştir. Delta hepatitine bağlı kompanse karaciğer sirozu zemininde HSK gelişen ve yttrium-90 ile başarılı kemoembolizasyonu yapılan 55 yaşında erkek hasta sunulmuştur.

🔖

Cite This Article

UYANIKOĞLU, A., AKYÜZ, F., ERMİŞ, M. F., KAYMAKOĞLU, S. (2014). Delta Hepatitine Bağlı Sirozlu Hastada Hepatosellüler Kanserin Yttrium-90 ile Radyoembolizasyon Tedavisi: Olgu Sunumu. Viral Hepatitis Journal, Cilt: 20 - Sayı: 3, 131–133. https://ajindex.com/articles/332835

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Wang z, zhang G, Wu J, Jia M. adjuvant therapy for hepatocellular carcinoma: current situation and prospect. Drug Discov Ther. 2013; 7(4): 137-143. 2. özer B, Serin e, Yılmaz u, Gümürdülü Y, Saygılı oB, kayaselçuk F, Boyacioğlu S. Clinicopathologic features and risk factors for hepatocellular carcinoma: Results from a single center in southern Turkey. Turk J Gastroenterol. 2003; 14(2): 85-90. 3. uyanıkoğlu a, Coşkun M, albayrak F, öztürk Y, Tay a, kibar Yİ. Genç yaşta hepatsellüler karsinoma İle Prezente olan, hepatit B’ye Bağlı İki karaciğer Sirozu vakası [Two Cases with liver Cirrhosis Secondary to hepatitis B that Prezented with hepatocellular at Young age]. Dicle Tıp Dergisi. 2013; 40(1): 131-133
  2. Fattovich G, Giustina G, Christensen e, Pantalena M, zagni I, Realdi G, Schalm SW. Influence of hepatitis delta virus infection on morbidity and mortality in compensatedcirrhosis type B. The european Concerted action on viral hepatitis (eurohep). Gut. 2000; 46(3): 420-426. 5. uyanıkoğlu a, Coşkun M, albayrak F, aktaş F, Binici Dn, öztürk Y. erzurum İli ve Çevresinde kan Donörlerinde hepatit B Seroprevalansı [Seroprevalance of hepatitis B among healty Blood Donors in erzurum region]. viral hepatit Dergisi [viral hepatitis Journal] 2012;18(3):91-93. 6. uyanıkoğlu a, aydoğan T, nar h, Çetin B, Sert u. Şanlıurfa Yöresinde hBsag (+) hastaların klinik Dağılımı ve Demografik özellikleri. IX. ulusal hepatoloji kongresi Bildiri özetleri kitabı. 28 Mayıs- 1 haziran 2013, İstanbul, P-059, 141. 7. albayrak a, Coşkun M, uyanıkoğlu a, Bayır Y, Yılmaz h, kibar Yİ, Tay a, albayrak F. kronik hepatit Delta’sı olan hastaların Pegile İnterferon Tedavi Yanıtlarının Değerlendirilmesi. vir hep Derg. 2012; 18(2): 68-70. 8. ettorre GM, laurenzi a, vennarecci G. Downstaging hepatocellular Carcinoma with Yttrium-90 radioembolization: Resection or transplantation? eur J Surg oncol. 2014; 40(6): 789-790. 9. vouche M, lewandowski RJ, atassi R, Memon k, Gates vl, Ryu Rk, Gaba RC, Mulcahy MF, Baker T, Sato k, hickey R, Ganger D, Riaz a, Fryer J, Caicedo JC, abecassis M, kulik l, Salem R. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J hepatol. 2013; 59(5): 1029-1036
  3. Memon k, lewandowski RJ, Riaz a, Salem R. Yttrium 90 microspheres for the treatment of hepatocellular carcinoma. Recent Results Cancer Res. 2013; 190: 207-224
  4. Romeo R, Foglieni B, Casazza G, Spreafico M, Colombo M, Prati D. high